Heart Disease News and Research

Latest Heart Disease News and Research

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Six research institutions awarded NIH grants to create database of human cellular responses

Building on a successful three-year pilot project, the National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses, the Library of Integrated Network-based Cellular Signatures.

15 Sep 2014

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Oraya Therapeutics Inc. announced that full results of three-year safety follow-up data from the INTREPID study of Oraya Therapy™ for wet age-related macular degeneration (AMD) further demonstrated a favorable safety profile and also showed that there was no significant difference in vision outcomes in patients treated with Oraya Therapy compared with those receiving anti-vascular endothelial growth factor (anti-VEGF) injections alone.

15 Sep 2014

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Combined treatment with a drug that mimics the action of a gut hormone and basal insulin is more effective at improving blood sugar control than other anti-diabetic treatments, with similar rates of hypoglycaemia (dangerously low blood sugar levels) and greater weight loss, a systematic review and meta-analysis published in The Lancet shows.

15 Sep 2014

Research roundup: Prevention services for seniors; drug shortages

This policy brief reports the findings of a systematic review conducted by the Community Health Innovations in Prevention for Seniors (CHIPS) project. ... Clinical preventive services such as colorectal cancer screening and pneumococcal immunization can help reduce rates of premature death and disability. Yet, many older adults are not receiving the full set of clinical preventive services that have been proven effective and are considered "high value" in terms of their costs per life saved. Rates are particularly low among racial and ethnic minority older adults compared to national goals.

15 Sep 2014

Researchers report that dendritic cells can affect psoriasis

Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine.

15 Sep 2014

Breathing-based meditation practice can be effective treatment for PTSD

One of the greatest casualties of war is its lasting effect on the minds of soldiers. This presents a daunting public health problem: More than 20 percent of veterans returning from the wars in Iraq and Afghanistan have post-traumatic stress disorder, according to a 2012 report by RAND Corp.

12 Sep 2014

Missouri sets 72-hour wait for women seeking abortions

The Republican-controlled legislature overrode Democratic Gov. Jay Nixon's veto to enact one of the most stringent waiting periods in the nation that includes no exception for cases of rape or incest.

12 Sep 2014

New collaborative approach could help improve diabetes care in China

Diabetes has become a major public health crisis in China, with an annual projected cost of 360 billion RMB (nearly 35 billion British pounds) by 2030, but a new collaborative approach to care that uses registries and community support could help improve diabetes care, according to a new three-part Series about diabetes in China published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

FDA approves Contrave extended-release tablets for chronic weight management

Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

11 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

New research shows statins could reduce common diabetes complications

The development of common diabetes complications that can lead to blindness and amputations could be reduced by taking statins, indicates new research published in The Lancet Diabetes & Endocrinology.

11 Sep 2014

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules.

11 Sep 2014

Study looks at blood type and risk of cognitive impairment

People with blood type AB may be more likely to develop memory loss in later years than people with other blood types, according to a study published in the September 10, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Sep 2014

Continuing to work during depressive illness may offer employees certain health benefits

The collaborative study between the University Of Melbourne and the Menzies Research Institute at the University of Tasmania is the first to estimate the long-term costs and health outcomes of depression-related absence as compared to individuals who continue to work among employees with depression in Australia.

11 Sep 2014

People with diabetes may have six-fold higher risk of developing heart failure

People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.

11 Sep 2014

Researcher receives grant from NIH to study effect of malpractice risk, incentives on cardiac testing

Making sure patients receive correct treatment and care is an essential tenant of current health care reforms.

11 Sep 2014

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Employing a measure rarely used in sleep apnea studies, researchers at the UCLA School of Nursing have uncovered evidence of what may be damaging the brain in people with the sleep disorder - weaker brain blood flow.

11 Sep 2014

Latest health care products demonstrated at Novation's annual Innovative Technology Expo

Novation, the leading health care services company, held its annual Innovative Technology Expo today in Irving, Texas. Medical suppliers, both large and small, are at the Expo to demonstrate the latest innovative health care products and meet with hospital clinicians and decision makers.

10 Sep 2014

Dell, Terascala and TGen to install genomic data management solution at NCI

Dell, Terascala and the Translational Genomics Research Institute are installing state-of-the-art computing and programing specialized for human genome investigations at the National Cancer Institute.

10 Sep 2014

Heart Disease News and Research

Latest Heart Disease News and Research

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Six research institutions awarded NIH grants to create database of human cellular responses

Three-year safety data from INTREPID study of Oraya Therapy™ for wet age-related macular degeneration results announced

Gut hormone-drug combination therapy more effective at improving type 2 diabetes

Research roundup: Prevention services for seniors; drug shortages

Researchers report that dendritic cells can affect psoriasis

Breathing-based meditation practice can be effective treatment for PTSD

Missouri sets 72-hour wait for women seeking abortions

New collaborative approach could help improve diabetes care in China

FDA approves Contrave extended-release tablets for chronic weight management

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

New research shows statins could reduce common diabetes complications

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

Study looks at blood type and risk of cognitive impairment

Continuing to work during depressive illness may offer employees certain health benefits

People with diabetes may have six-fold higher risk of developing heart failure

Researcher receives grant from NIH to study effect of malpractice risk, incentives on cardiac testing

Researchers find that people suffering from sleep apnea have weaker brain blood flow

Latest health care products demonstrated at Novation's annual Innovative Technology Expo

Dell, Terascala and TGen to install genomic data management solution at NCI

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in